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ABSTRACT
MicroRNAs (miRNAs) are a class of small,
non-coding RNAs that play a pivotal role in the regu-
lation of posttranscriptional gene expression in a
wide range of eukaryotic organisms. Although DNA
viruses have been shown to encode miRNAs and
exploit the cellular RNA silencing machinery as a
convenient way to regulate viral and host gene ex-
pression, it is generally believed that this pathway is
not available to RNA viruses that replicate in the
cytoplasm of the cell because miRNA biogenesis is
initiated in the nucleus. In fact, among the >200 viral
miRNAs that have been experimentally verified
so far, none is derived from an RNA virus. Here,
we show that a cytoplasmic RNA virus can indeed
encode and produce a functional miRNA. We
introduced a heterologous miRNA-precursor stem-
loop sequence element into the RNA genome of the
flavivirus tick-borne encephalitis virus, and this led
to the production of a functional miRNA during viral
infection without impairing viral RNA replication.
These findings demonstrate that miRNA biogenesis
can be used by cytoplasmic RNA viruses to produce
regulatory molecules for the modulation of the
transcriptome.
INTRODUCTION
MicroRNAs (miRNAs) are a class of short ( 21–25nt),
single-stranded non-coding RNA molecules that play a
critical role in many cellular processes, such as cell devel-
opment, differentiation, apoptosis and oncogenesis (1–3).
They exert their suppressive activity on gene expression by
guiding the RNA-induced silencing complex (RISC) to
complementary RNA stretches within a speciﬁc messenger
RNA. The biosynthesis of the vast majority of miRNAs
involves the sequential action of two RNAse III enzymes,
Drosha and Dicer (4). A larger RNA precursor containing
a characteristic miRNA hairpin structure is transcribed in
the nucleus. This so-called primary miRNA is recognized
by Drosha (acting with cofactor DGCR8) and cleaved
into a  70-nt stem-loop RNA intermediate (precursor-
miRNA, premiRNA), which is then transported by
exportin-5 to the cytoplasm, where it undergoes process-
ing by Dicer, and gives rise to a mature, single-stranded
miRNA (5–11).
The number of identiﬁed miRNAs in plants and
animals is rapidly increasing, and >700 miRNAs are
known so far in humans (12). The ﬁrst miRNAs expressed
from human viruses were discovered in 2004 (13). Since
then, >200 miRNAs have been described, but up to now,
all of them have been derived from viruses with a nuclear
DNA stage in their replication cycle, mainly of the her-
pesvirus family (12,14). Although computer algorithms
have also predicted the existence of miRNA hairpins in
viruses with RNA genomes (15), a study involving the
cloning of small RNAs from cells infected with two
positive-strand RNA viruses, hepatitis C virus (HCV)
and yellow fever virus (YFV), did not result in the
identiﬁcation of any RNA virus-derived small interfering
RNAs (siRNAs) or miRNAs (16). A recent paper by
Parameswaran et al. (17) identiﬁed virus-derived small
RNAs (vsRNAs) in a wide range of vertebrate cells
infected with RNA viruses, such as Dengue, West Nile
and HCV. However, there was no evidence that these
small RNAs included miRNAs, and precursor structures
or physiological relevance of the discovered vsRNAs
remain to be elucidated.
In the present study, we investigated whether
RNA viruses are fundamentally capable of producing
functional miRNA, by inserting a known miRNA
element into the genome of an RNA virus whose life
cycle is conﬁned to the cytoplasm of the host cell.
Thereby we show that a functional miRNA can indeed
be produced during infection without imparing viral
RNA replication.
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Viruses and cells
Western subtype TBEV strain Neudoerﬂ, which has been
characterized in detail, including the determination of its
entire genomic sequence (18,19) (GenBank accession no.
U27495), was used as the wild-type control in all infection
experiments, and all mutants described in this study were
derived from this strain.
The Epstein-Barr virus (EBV) miR-BART2 sequence
was obtained from genomic DNA of human herpesvirus
4 [EBV (20), GenBank accession no. V01555].
BHK-21 cells were grown at 37 C with 5% CO2 in
Eagle’s minimal essential medium (Sigma) supplemented
with 5% fetal calf serum (FCS), 1% glutamine and 0.5%
neomycin (growth medium) and were maintained in
Eagle’s minimal essential medium supplemented with
1% FCS, 1% glutamine, 0.5% neomycin and 15mM
HEPES, pH 7.4 (maintenance medium).
Mutant construction
All viral constructs described in this study are derivatives
of pTNd/c, an infectious cDNA clone of TBEV strain
Neudoerﬂ (21). To create variants containing the
miR-BART2 precursor stem-loop and ﬂanking EBV
sequence, DNA was ampliﬁed from EBV B95-8 genomic
DNA using primers 50-ATCGACCGGTATGCCACCTC
CCTGCCTG-30 and 50-CGATACCGGTGCGTGGCCC
GTGGATCTG-30. The PCR product was digested with
AgeI and ligated with AgeI-digested reporter replicon con-
struct C17, yielding C17 BART(+) or C17 BART( ), de-
pending on the orientation of the insert. C17 is a modiﬁed
version of the previously described construct
C17ﬂuc-TaV2A (22) in which the ﬁreﬂy luciferase (ﬂuc)
start codon ATG was deleted. C17 matBART(+) was con-
structed by ﬁrst annealing oligonucleotides 50-CCGGACT
ATTTTCTGCATTCGCCCTTGCGT-30 and 50-CCGGA
CGCAAGGGCGAATGCAGAAAATAGT-30, resulting
in a double-stranded DNA fragment with AgeI overhangs
and then ligating this fragment with AgeI-digested C17
plasmid DNA. Full-length infectious cDNA clones were
constructed by excising an XbaI/NheI fragment from each
C17 replicon and inserting it into the corresponding site of
XbaI/NheI-digested pTNd/c.
The non-replicating C17 variant C17 BART(+)GAA
was constructed by replacement of the NS5 coding
sequence of C17 BART(+) with an KpnI/XbaI-digested
fragment of the previously described reporter replicon
mutant NS5-GAA. The sequences of all constructs in
this study were conﬁrmed using an automated DNA
sequencing system (PE Applied Biosystems, GA3100).
Reporter constructs and luciferase assays
To construct the luciferase reporter plasmids
psiCHECK1-BART2 and psiCHECK2-BART2, oligo-
nucleotides 50-TCGAGCGCAAGGGCGAATGCAGAA
AATAGT-30 and 50-GGCCACTATTTTCTGCATTCG
CCCTTGCGC-30, containing XhoI and NotI overhangs,





TM Luciferase Assay System (Promega)
was used according to the manufacturer’s instructions
to measure both ﬁreﬂy and Renilla luciferase (Rluc)
activity simultaneously. For experiments with infectious
viruses, cells were electroporated (EP) with 6mg
psiCHECK2-BART2 plasmid DNA using a Gene Pulser
apparatus (Bio-Rad). One day after electroporation,
60000 cells/well were seeded in 96-well plates for subse-
quent infection in triplicate with wild-type and mutant
virus at an MOI of 10. Renilla and ﬂuc levels were
determined immediately after infection and at 24 and
48h post infection. For experiments using non-infectious
replicons, cells were coelectroporated with equimolar
amounts of in vitro-transcribed replicon RNA (corres-
ponding to  1.2 10
12 RNA copies) and 6mg
psiCHECK1-BART2 plasmid DNA. Procedures for
RNA in vitro transcription and electroporation of




5 cells were seeded onto individual
glass cover slips in 24-well plates prior to infection (TNd/c
mutant set) or after transfection (C17 mutant set).
Immunoﬂuorescence (IF) staining was performed 24h
after infection with TNd/c mutants or 48h after transfec-
tion with replicon RNA. Cells were permeabilized by
acetone-methanol (1:1) ﬁxation, and viral proteins were
detected by incubation with rabbit anti-TBEV serum
and a ﬂuorescein-isothyocyanate-conjugated anti-rabbit
antibody (Jackson ImmunoResearch Laboratories).
Northern blot analysis
miRNA-BART2 northern blotting. Total RNA was ex-
tracted using a mirVana miRNA Isolation Kit (Ambion)
following the vendor’s recommendations. Of total RNA,
20mg per sample was electrophoresed through a
12%-urea-polyacrylamide gel, which was stained with
ethidium bromide for visualization of bands and then
electroblotted to Hybond XL nylon membranes (GE
Healthcare). A mirVana miRNA Probe Construction Kit
(Ambion) and [alpha-
32P] CTP (Hartmann Analytic) were
used to construct a radioactive RNA probe (50-GCAAGG
GCGAAUGCAGAAAAUA-30) complementary to EBV
miR-BART2-5p. Blots were hybridized overnight in
PerfectHyb
TM Plus (Sigma) hybridization buffer at 50 C
and then washed twice with 5  SSC+1% SDS and twice
for 15min with 1 SSC+1% SDS prior to signal detec-
tion on a phosphorimager. Cells EP with synthetic
miRNA (Pre-miR
TM miRNA Precursor Molecules,
Ambion) at a concentration of 30nm were used as
positive controls.
Northern blot of subgenomic RNA. 1mg of total RNA,
extracted from BHK-21 cells using a mirVana miRNA
isolation Kit (Ambion), was subjected to denaturing gel
electrophoresis using a Northern MaxGly Kit (Ambion)
and transferred to a positively charged nylon membrane
(BrightStar Plus, Ambion) according to the manufactur-
er’s recommendations. Two different probes were
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Ambion) using biotinylated UTP (Ambion). Templates
for in vitro transcription were generated by PCR ampliﬁ-
cation of pTNd/c-BART(+) DNA using the following T7
promoter primers: 50-CAGGGGTGAGGAATGCCCCC
AGA-30 and 50-TAATACGACTCACTATAGGGCGG
GTGTTTTTCCGAGTCAC-30, yielding a probe comple-
mentary to the core 30-NCR of TBEV and 50-ATGCCAC
CTCCCTGCCTGGTGGAC-30 and 50-TAATACGACT
CACTATAGGGCGTGGCCCGTGGATCTGTGAA-30,
yielding a probe speciﬁc for the miR-BART2 sequence
insertion, including the EBV ﬂanking regions.
Hybridization and washing steps were performed accord-
ing to the manual, and these were followed by a
non-isotopic detection procedure (Bright Star Biodetect
Kit, Ambion).
Time course analysis of miR-BART2 expression levels
Total RNA from infected cells was extracted using a
mirVana miRNA Isolation Kit (Ambion). TaqMan
TM
miRNA Assays (Applied Biosystems) speciﬁc for EBV
BART2-5p and U6 snRNA (endogenous control) were
performed according to the manufacturer’s protocol
using an ABI 7300 Real-Time PCR System (PE Applied
Biosystems). Relative quantiﬁcation was carried out using
the 2
 T method (23) for infected versus uninfected cells.
Quantiﬁcation of TBEV genomic RNA and mature
miR-BART2
To quantify the number of genomic TBEV RNA per cell
in comparison to the number of mature miRNA-BART2
derived from these genomes, standardized real-time PCR
was performed. Equal numbers of cells (5 10
4), as
counted in a Casy TT cell counter (Scha ¨ rfe Systems),
were collected and total RNA was extracted using the
mirVana miRNA Isolation Kit (Ambion). cDNA synthe-
sis for qPCR of genomic TBEV RNA was performed
using an iScript cDNA Synthesis Kit (BioRad) and
real-time PCR was carried out on a BioRad iCycler.
Primer, probe sequences and the temperature proﬁle
were selected as described in a previous study (24). Copy
numbers of viral RNA were determined by comparison of
the result to a standard curve that was prepared by using a
serial 10-fold dilution of DNAse treated, in vitro
transcribed full length RNA of known concentration.
In parallel, the same mirVana total RNA preparation
was used to determine the copy number of mature
miRNA-BART2 molecules in a TaqMan
TM miRNA
Assay according to the manufacturer’s protocol. A
10-fold serial dilution of the RNA-oligonucleotide 50-UA
UUUUCUGCAUUCGCCCUUGC-30 (corresponding to
mature miR-BART2-5p) was used as a standard curve.
Virus production, passaging and focus assay
For the production of infectious virus particles, BHK-21
cells were transfected with equal amounts of in vitro-
transcribed full-length RNA. The supernatant from the
transfected cells was collected 48h post infection and
cleared by centrifugation. Various dilutions were applied
to conﬂuent cell monolayers to determine the number of
focus-forming units (ffu). Fifty hours postinfection, cells
were ﬁxed with acetone-methanol (1:1) and treated with
polyclonal rabbit anti-TBEV serum. Antibody-labeled
cells were detected using an immunoenzymatic reaction
consisting of successive incubations with goat anti-rabbit
immunoglobulin G-alkaline phosphatase and the corres-
ponding enzyme substrate (SigmaFast Red TR/Naphtol
AS-MX tablets). To analyze the genomic stability of the
viral mutants and to increase the titer, viruses for infection
experiments were passaged at least ﬁve times, using a
1:5000 dilution of the supernatant.
Drosha knockdown studies
Knockdown studies were performed using shRNA
plasmids (Santa Cruz Biotechnology) in HeLa cells. Cells
were transfected with 1mg Drosha short hairpin plasmid
sc-44080-SH or negative control shRNA plasmid-A
sc-108060 and 0.5mg reporter plasmid psiCHECK2-
BART2 in 6-well plates using Lipofectamine 2000
(Invitrogen). Cells were trypsinized 24h after transfection,
pooled and seeded in 96-well plates. Infection with TNd/c
or TNd/c BART(+) was initiated 48h after the initial
shRNA/reporter plasmid transfection. The luciferase
assay was carried out as outlined above. Knockdown efﬁ-
ciency in parallel to the luciferase assay was determined at
the protein level by western blotting using a rabbit poly-
clonal antibody to Drosha (Abcam) and a mouse mono-
clonal antibody to GAPDH (Ambion). Corresponding
secondary antibodies for ECL detection (Amersham)
were purchased from Jackson Immunoresearch.
RESULTS
Construction of a cytoplasmic RNA virus encoding a viral
miRNA
For these experiments, we used tick-borne encephalitis
virus (TBEV), a human pathogen of the genus
Flavivirus, family Flaviviridae. Like all members of this
family of positive-strand RNA viruses, the replication
cycle of TBEV takes place in the cytoplasm. Its genome
consists of a single RNA molecule of  11kb in length,
which also serves as a messenger RNA, encoding a single
polyprotein precursor that is processed to form three
structural proteins (C, prM, E), which together with the
genomic RNA compose the virion, and seven
non-structural proteins (NS1, NS2A, NS2B, NS3,
NS4A, NS4B, NS5) that are necessary for replication
(Figure 1A) (25–27).
The 30-NCR of TBEV has been shown to tolerate the
insertion of heterologous sequence elements (22). We took
advantage of this ﬂexibility to insert the miR-BART2
hairpin precursor from the herpesvirus EBV between the
variable and core regions of the 30-NCR of a wild-type
TBEV strain (TNd/c, Figure 1B and C). miR-BART2
downregulates expression of the EBV DNA polymerase
BALF5, and this is thought to prevent the transition
from latent to lytic replication (16,28,29). To favor
proper formation of the stem-loop secondary structure,
which is crucial for recognition by the classical miRNA-
processing machinery (6,30,31), we decided to add
8330 Nucleic Acids Research, 2010,Vol.38, No. 22ﬂanking EBV sequence on either side of the hairpin. We
generated three different BART mutants. The EBV
miR-BART2 precursor was introduced in the plus-strand
(messenger-sense) orientation [TNd/c BART(+)] and also
as the reverse complement [TNd/c BART( )] to allow a
potentially functional miRNA precursor to be formed at
the 50-end of the negative-strand (antisense) copy of the
viral RNA during replication. Bioinformatic secondary
structure analysis prior to construction of these mutants
prompted us to add 30nt of original genomic EBV
sequence on either side of the hairpin, resulting in a toler-
able maximum of 128nt for the full-hairpin insertions.
In a third construct, only the ‘mature’ miR-BART2
sequence, devoid of any EBV-derived ﬂanking sequences
or hairpin structure elements, was inserted [TNd/c
matBART(+)]. To assess the capability of these TBEV
BART mutants to replicate and be translated, RNA
from the mutants and wild-type TBEV was made by
Figure 1. TNd/c BART mutants and reporter plasmid psiCHECK2-BART2. (A) Genome organization of wild-type TBEV virus strain Neudoerﬂ
(TNd/c). 50-NCR, 50-non-coding region; 30-NCR, 30-non-coding region. The positions of the ‘variable’ and conserved ‘core’ regions of the 30-NCR are
indicated. (B) EBV miR-BART2 precursor in the predicted secondary structure (miRBase accession number: MI0001068) ﬂanked by 30nt of EBV
B95-8 sequence on either side. The sequence of the precursor of miR-BART2 is highlighted in red and blue, with the red region corresponding to the
mature miR-BART2. (C) Top: Schematic diagram of the 30-NCR of parental virus TNd/c and the derived TNd/c BART mutants. Below: IF staining
of infected cells with rabbit anti-TBEV serum 24h postinfection. (D) Mature miR-BART2 (red) and the corresponding target sequence in the 30-UTR
of the EBV BALF5 mRNA (green) that was inserted into the 30-UTR of the Rluc mRNA gene of the parental vector psiCHECK-2. The ﬂuc
expressed from the HSV-TK promoter served as an internal standard. Promoters are indicated by ﬂags: SV40, simian virus 40; HSV-TK, herpes
simplex virus thymidine kinase. Diagrams are not drawn to scale.
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electroporation. IF staining with an anti-TBEV serum
24h after transfection showed that all three mutants
were able to replicate and express viral proteins (Figure
1C), indicating that the inserted miRNA hairpin structure
elements did not impair viral RNA replication or protein
expression.
Next, we examined the stability of the heterologous
sequence elements in a passage experiment on BHK-21
cells. After ﬁve rounds of sequential infection with
diluted supernatant from the previous passage, no
sequence changes could be detected in the inserted
miR-BART2 sequences or the ﬂanking elements. The
only mutations observed were ones that occurred in the
viral envelope protein E and were of a type previously
associated with cell culture adaptations (Supplementary
Table S1) (32,33). Taken together, these results
demonstrated that the insertion of a miRNA hairpin pre-
cursor in either orientation into the RNA genome of this
ﬂavivirus was genetically stable and compatible with viral
growth.
Functional activity of the inserted miRNA
As a tool to measure the functional activity of
miR-BART2, we established a dual-luciferase reporter
assay. The original miR-BART2 target sequence was
inserted downstream of the translational stop codon of
the Rluc coding sequence of the siRNA evaluation
vector psiCHECK
TM-2, yielding a construct encoding an
Rluc mRNA fused to a miR-BART2 target site, termed
psiCHECK2-BART2 (Figure 1D). The ﬂuc on the same
plasmid, driven from a second promoter, served as an
internal control. As expected, Rluc expression from this
construct was suppressed in a dose-dependent manner
upon transfection with synthetic miR-BART2
(Supplementary Figure S1A). To investigate whether the
viral mutants TNd/c BART(+), TNd/c BART( ) and
TNd/c matBART(+) were able to downregulate reporter
gene expression, BHK-21 cells were transfected with
psiCHECK2-BART2 and 24h thereafter infected with
BART mutants or wild-type virus. TNd/c BART(+)
clearly suppressed reporter gene expression at 24 and
48h post infection (Figure 2A). The observed reduction
by  50% is equal to the effect seen with the natural
miR-BART2 target BALF5 protein in EBV-infected cells
with forced miR-BART2 expression (28). In contrast,
infection of cells with TNd/c BART( ) or TNd/c
matBART(+) did not decrease reporter gene expression.
Time course of miR-BART2 generation during infection
To obtain direct evidence for the formation of
miR-BART2, total RNA was isolated from infected cells
and subjected to northern blot analysis 24h after infection
(Figure 2B). Consistent with the data from the luciferase
assay, mature miRNA and the corresponding pre-miR
were readily detected in cells infected with TNd/c
BART(+), but not in samples of the other mutants or
wild-type virus. To establish a time course of miRNA for-
mation in infected cells, we performed a TaqMan
TM
miRNA Assay (Figure 2C). In cells infected with TNd/c
BART(+), levels of miR-BART2 increased within 24h to
a maximum plateau level, whereas the signal detected for
TNd/c BART( ) and TNd/c matBART(+) remained at or
close to background levels.
Dependence of miRNA production on replication
of viral RNA
The experiments described above consistently indicated
that signiﬁcant amounts of functional miR-BART2 were
generated with TNd/c BART(+) and prompted a more
detailed investigation of the relationship between RNA
replication and miRNA formation. For this purpose, we
prepared an analogous set of replicons [C17 BART(+),
C17 BART( ) and C17 matBART(+)] based on the
TBEV reporter replicon C17ﬂuc-TaV2A, a construct in
which the viral structural proteins had been replaced by
an in-frame insertion of the ﬂuc gene (Figure 3A) (22).
Additionally, we designed a replication-negative variant
of C17 BART(+) with a GDD-to-GAA mutation in the
active site of the viral polymerase, termed C17
BART(+)GAA (Figure 3A). IF staining with an anti-
TBEV antiserum 48h after transfection conﬁrmed that
all of the replicons encoding a functional RNA polymer-
ase were able to replicate and express viral proteins
(Figure 3A, bottom).
Replication of these replicons was monitored by meas-
urement of ﬂuc activity in transfected BHK-21 cells, and
this revealed that the insertion of the miRNA sequence (in
either orientation or in its mature form) did not alter the
level of RNA replication relative to the parental C17
replicon (Figure 3B). As expected, and consistent with
the IF results, C17 BART(+)GAA was negative for
RNA replication. To conﬁrm that miRNA formation
from these replicons mirrored the ﬁndings with infectious
virus, functional miR-BART2 activity was assayed by
measuring Rluc reporter gene repression (Figure 3C;
see Supplementary Figure S2 for a complete data set)
using a modiﬁed reporter plasmid lacking ﬂuc,
psiCHECK1-BART2 (Figure 3D). C17 BART(+) clearly
suppressed reporter gene activity, and the presence of
the miRNA was additionally conﬁrmed in a northern
blot assay (Figure 3E). In contrast, no activity and
no miRNA was observed for C17 BART( ), C17
matBART(+) or the parental control C17. Notably, the
replication-deﬁcient control C17 BART(+)GAA also did
not suppress Rluc expression or generate detectable
miRNA (Figure 3C and E).
miRNAs are produced at lower molar concentrations
than viral RNA
Apparently, miRNA formation did not signiﬁcantly
impair viral RNA replication which by itself was necessary
for efﬁcient miRNA production. This raised the question
to which extent the viral plus-stranded RNA molecules
were processed into mature miR-BART2 molecules. To
answer this question, concentrations of both viral RNA
and miR-BART2 were determined by qPCR at various
time points post infection. As depicted in Figure 4, viral
RNA replication of TNd/c and TNd/c BART(+) was
identical. The number of genomic TBEV RNA molecules
8332 Nucleic Acids Research, 2010,Vol.38, No. 22of both the wild-type and the mutant viruses reached a
value of  7 10
4 copies per cell 48h after infection. In
contrast, the copy number of mature miR-BART in cells
infected with TNd/c-BART(+) reached a concentration of
about 500 miRNA molecules per cell 48h post infection.
This indicates that <1% of the viral RNA needed to be
processed to generate a functionally active concentration
of miRNAs.
The role of Drosha in miRNA biogenesis from the
TBEV genome
Pathways that completely bypass Drosha cleavage have
been reported recently [reviewed in (34)]. To investigate
whether miRNA generation from the TBEV genome
involves Drosha, we performed a transient shRNA
knockdown. We cotransfected human HeLa cells with
the luciferase reporter plasmid psiCHECK2-BART2 and
Drosha-speciﬁc or negative-control shRNA plasmids. As
shown in Figure 5A, transfection with Drosha-speciﬁc
shRNA plasmids resulted in strong downregulation of
Drosha protein expression 72–96h after transfection but
was unaffected by the delivery of a negative control
shRNA plasmid encoding a scrambled sequence.
Monitoring reporter gene expression in transfected cells
24 and 48h after infection with TNd/c BART(+) and
the wild-type virus (corresponding to 72 and 96h after
the initial shRNA transfection) revealed a measurable
difference in miRNA activity between the Drosha-
knockdown and control cells. As observed with BHK-21
cells, reporter gene expression in HeLa cells expressing
normal Drosha levels was clearly reduced upon infection
with TNd/c BART(+). However, Rluc expression did not
appear to be suppressed after knockdown of Drosha
(Figure 5B) suggesting that Drosha was involved in
miRNA formation from the ﬂavivirus.
DISCUSSION
This is the ﬁrst study that describes the generation of
a functional miRNA from a cytoplasmic RNA virus.
Figure 2. A functional miRNA is produced during infection with TBEV mutant TNd/c BART(+). (A) Relative Rluc activity after infection with
TNd/c BART mutants. BHK-21 cells were transfected with psiCHECK2-BART2 and 24h thereafter infected with viral mutants at an MOI of 10.
Values represent Rluc expression levels relative to the infection with wild-type virus. Error bars indicate SD of three experiments, each measured in
triplicate. (B) Northern-blot analysis of intracellular RNA 24h after infection using a radioactive complementary RNA probe speciﬁc for the mature
miR-BART2 sequence. Cells EP with synthetic miRNA-BART2 (syn. miRNA) served as a positive control. (C) Time course analysis of miR-BART2
expression in BHK-21 cells infected at an MOI of 10. At the indicated time points, total RNA of infected cells was isolated and subjected to a
TaqMan
TM miRNA Assay speciﬁc for mature miR-BART2. U6 snRNA served as an endogenous control. The CT value of uninfected cells at time
point 0 was used as a base value to calculate fold change in expression by the comparative CT method.
Nucleic Acids Research, 2010,Vol.38, No. 22 8333Figure 3. RNA replication is necessary for but not affected by miRNA biogenesis. (A) Top: schematic diagram of parental luciferase reporter
replicon C17, which contains the ﬁrst 17 aa of the capsid protein and has the rest of the structural proteins replaced by ﬂuc. The 30-NCR of each
replicon is identical to that of the corresponding TNd/c virus mutant (Figure 1C). Replication-negative C17 BART(+)GAA differs from C17
BART(+) by a GDD-to-GAA mutation in the polymerase active site of the viral NS5 protein. Below: IF staining with rabbit anti-TBEV serum
48h post transfection. (B) Replication efﬁciencies of the C17 BART mutant set monitored by ﬂuc activity in BHK-21 cells. Error bars represent the
SD of three independent experiments, each measured in triplicate. (C) Relative Rluc activity in BHK-21 cells co-transfected with miR-BART2
reporter plasmid psiCHECK1-BART2 and the C17 BART mutants C17 BART(+) and C17 BART(+)GAA. Rluc levels are shown as a percentage of
the level obtained with the parental replicon C17. Error bars represent the SD calculated from a minimum of three independent experiments, each
measured in triplicate. (D) Schematic diagram of the reporter plasmid psiCHECK1-BART2, which contains the miR-BART2 target sequence fused
to the Rluc-coding sequence under the control of an SV40 promoter. (E) Relative Rluc activity of C17 BART mutants at 48h post transfection (top)
and northern blot analysis (below) of the same intracellular RNA preparation used in the Rluc assay. The positions of the precursor and the mature
miRNA are indicated by arrows. Total RNA of cells EP with synthetic miR-BART2 (syn. miRNA) served as a control. Diagrams (A) and (D) are
not to scale.
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barriers are generally thought to impede miRNA biogen-
esis for this class of viruses: ﬁrst, in contrast to DNA and
retroviruses, the replication cycle of cytoplasmic RNA
viruses takes place in the cytoplasm, away from the
nucleus where Drosha resides and initiates the processing
of the miRNA hairpin structure for a majority of all
known miRNAs. Second, even if the miRNA precursor
could be liberated from an RNA virus genome, this
excision event would be expected to destroy copies of
the viral genome and thereby reduce RNA replication
efﬁciency.
A detailed follow-up study has to be carried out now, to
clarify, how and where the miRNA is generated in our
system, and which key players of the classical miRNA
biogenesis pathway are involved in this process.
Regardless of the mechanism, however, our results dem-
onstrate that these barriers are not absolute and that they
can eventually be circumvented.
One possible way in which this could occur is that viral
infection might lead to a partial breakup of cellular com-
partmentalization or to protein retrafﬁcking, allowing the
Drosha complex to act in the cytoplasm. Another possi-
bility is that a fraction of the ﬂavivirus RNA containing
the miRNA-BART2 precursor enters the nucleus. Many
positive- and negative-stranded RNA viruses with a cyto-
plasmic replication cycle have been reported to alter
nuclear-cytoplasmic trafﬁcking to expedite viral growth
(35), and the presence of ﬂaviviral RNA in the nucleus
has been suggested in a recent study (36). First experi-
ments, performed to unravel the role of Drosha, point in
this direction and do not suggest a Drosha-independent
pathway. As it is becoming clear since recently that also
non-canonical pathways can lead to the generation of
functional miRNAs (5,34), it remains possible, however,
that the activity of this enzyme is bypassed. One such
pathway, in which miRNA precursors are fed into the
miRNA maturation pathway without a contribution of
Drosha, is the mirtron pathway (37–39). In this case,
pre-miRNAs are formed from debranched introns
during mRNA splicing.
One of the most important ﬁndings of our study is that
while active viral replication was required for production
of miRNA-BART2, the presence of the functional
miRNA precursor element in the TBEV genome did not
have a measurable negative impact on RNA replication.
Remarkably, in a recent study, it was found that several
ﬂaviviruses produce a 30-terminal non-coding RNA
fragment that accumulates in infected cells due to
incomplete degradation of viral genomic RNA (40). This
highly structured, nuclease-resistant RNA was shown
to increase both virus replication and virus-induced
cytopathogenicity, although the reason for this is still
Figure 5. The involvement of Drosha in the generation of miR-BART2
from TNd/c BART(+). HeLa cells were transfected with shRNA
plasmids targeting human Drosha and a negative control shRNA
plasmid encoding a scrambled sequence (shRNA neg. co.). (A)
Western blot showing the expression of Drosha. GAPDH was used
as a loading control. (B) Transfected cells were subjected to infection
with TNd/c BART(+) and TNd/c wild-type virus with a viral dose
corresponding to an MOI of 100 on BHK-21 cells. Time points
24 and 48h post infection correspond to 72 and 96h after shRNA
transfection. Rluc expression levels in shRNA-transfected cells
that were infected with TNd/c BART(+) are depicted relative to
shRNA-transfected cells infected with wild-type virus. Error bars
represent the SD of three independent experiments, each measured in
triplicate.
Figure 4. Quantiﬁcation of viral genomic RNA and derived mature
miR-BART2. BHK-21 cells were infected with TNd/c and TNd/c
BART(+) at an MOI of 10. At the indicated time points 5 10
4 cells
were collected and total RNA was isolated. Copy numbers of the viral
genome were determined by qRT-PCR using a standard curve of
in vitro transcribed full-length RNA. Copy numbers of mature
miR-BART2 were determined in parallel by employing a synthetic
RNA oligonucleotide for the generation of a standard curve in a
TaqMan
TM miRNA Assay speciﬁc for mature miR-BART2. Data
points represent geometric mean values from duplicate experiments,
with error bars indicating SD.
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mentation processes can also be beneﬁcial and that
RNA viruses can indeed use such mechanisms to
generate smaller RNA molecules with biological activity
without the need for sub-genomic promoters. In further
experiments, we found that TBEV-infected cells also
contain relatively large amounts of a 30-terminal
sub-genomic RNA and that the amount of this RNA
present in the cell is not altered by the insertion of the
BART2 sequence element (Supplementary Figure S3).
Regardless of the mechanism of miRNA precursor pro-
cessing from the genomic viral RNA molecule, our data
indicate that miRNA copy numbers were at least 100-fold
lower than the number of genomic RNAs present in the
cell. This provides an explanation why RNA replication
was not impaired by the insertion of the miRNA precursor
sequence because as little as 0.5–1% of the pool of
genomes present in the cell would sufﬁce to give rise to
the observed levels of mature miRNA. Due to the fact that
many RNA viruses, including ﬂaviviruses, replicate to
very high copy numbers, this mechanism allows produc-
tion of physiologically active levels of miRNA without
having to sacriﬁce a relevant proportion of the genomic
RNA molecules. We also found that although insertion of
the natural miRNA-BART2 hairpin precursor, with
ﬂanking sequences from the EBV genome, into the
TBEV 30-NCR in the plus-strand (messenger-sense) orien-
tation led to production of a mature, functional miRNA,
insertion of only the portion corresponding to mature
miRNA-BART2 did not. This further emphasizes that
the resulting mature miRNA was not simply a remaining
piece of randomly degraded viral RNA but indeed the
product of an active miRNA processing pathway.
Interestingly, the insertion of the same miRNA-BART2
precursor in the antisense orientation did not result in
miRNA production. Since all of the constructs tested
were genetically stable over multiple passages and appar-
ently had no effect on the efﬁciency of viral RNA replica-
tion, we conclude that there must be speciﬁc mechanistic
reasons for the requirement of the precursor element to be
in the positive-sense orientation. First, the replication of
ﬂaviviruses is asymmetrical, meaning that viral plus
strands accumulate in around 10-fold excess over the cor-
responding genome-length minus strands (25). Second, the
minus-strand RNA template may be inaccessible to the
miRNA machinery when it is in the ER-associated viral
replication complex. Recent biochemical analysis has sug-
gested that the ﬂavivirus replication complex resides in
virus-induced double-layered membrane compartments
(41). Therefore, it seems reasonable that the minus
strand remains shielded from other cellular compartments
and enzymes. The plus strand, in contrast, is forced to
leave the site of replication to gain access to the cellular
translation machinery.
The results of this study demonstrate that, contrary to
current assumptions, RNA viruses can carry functional
miRNA elements. Future studies will have to address
whether similar results can be obtained with different
viral or cellular miRNAs, when inserted into various
genomic locations or into various other viral species
derived from the spectrum of RNA virus families.
A result published during the review process of our manu-
script, provides compelling evidence that this may indeed
be possible. Varble et al. (42) engineered a celluar miRNA
hairpin into the genome of inﬂuenza virus and reported
the synthesis of a functional miRNA without a negative
impact on viral replication. Orthomyxoviruses, such as
inﬂuenza, are segmented, negative-stranded RNA viruses
which employ the host cell nucleus for replication.
Although mechanisms of miRNA formation likely may
differ, this report supports the notion that RNA viruses
can encode miRNAs. It is tempting to speculate that
among the vast assortment of diverse RNA viruses
found in nature, some may indeed naturally encode
miRNAs and use them as part of their replication
strategy to regulate viral or host gene expression.
A more comprehensive search for natural miRNAs
among many different RNA viruses seems warranted in
the light of the current ﬁndings. Regardless of whether or
not miRNAs are found to play a physiological role in their
biology, our study demonstrates that their generation is
mechanistically possible. This knowledge opens up new
avenues for the rational design of RNA virus mutants
and vectors encoding this important class of regulatory
molecules.
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